RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials. Harris E. JAMA 2023 Apr 12. doi: 10.1001/jama.2023.6254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harris E. RSV Vaccine, Monoclonal Antibody Safe, Effective in Phase 3 Trials. JAMA 2023 Apr 12. doi: 10.1001/jama.2023.6254.
PMID: 37043257